Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Saliva changes in composition associated to COVID- 19: a preliminary study (CROSBI ID 312504)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Munoz-Prieto, Alberto ; Rubic, Ivana ; Carlos Gonzalez-Sanchez, Juan ; Kuleš, Josipa ; Martinez-Subiela, Silvia ; Joaquin Ceron, Jose ; Bernal, Enrique ; Torres-Cantero, Alberto ; Rosario Vicente-Romero, Maria ; Mrljak, Vladimir et al. Saliva changes in composition associated to COVID- 19: a preliminary study // Scientific reports, 12 (2022), 10879, 14. doi: 10.1038/s41598-022-14830-6

Podaci o odgovornosti

Munoz-Prieto, Alberto ; Rubic, Ivana ; Carlos Gonzalez-Sanchez, Juan ; Kuleš, Josipa ; Martinez-Subiela, Silvia ; Joaquin Ceron, Jose ; Bernal, Enrique ; Torres-Cantero, Alberto ; Rosario Vicente-Romero, Maria ; Mrljak, Vladimir ; Tvarijonaviciute, Asta

engleski

Saliva changes in composition associated to COVID- 19: a preliminary study

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2), is usually associated with a wide variety of clinical presentations from asymptomatic to severe cases. The use of saliva as a diagnostic and monitoring fluid has gained importance since it can be used to investigate the immune response and to direct quantification of antibodies against COVID-19. Additionally, the use of proteomics in saliva has allowed to increase our understanding of the underlying pathophysiology of diseases, bringing new perspectives on diagnostics, monitoring, and treatment. In this work, we compared the salivary proteome of 10 patients with COVID-19, (five patients with mild and five patients with severe COVID-19) and ten control healthy patients. Through the application of proteomics, we have identified 30 proteins whose abundance levels differed between the COVID-19 groups and the control group. Two of these proteins (TGM3 and carbonic anhydrase-CA6) were validated by the measurement of gGT and TEA respectively, in 98 additional saliva samples separated into two groups: (1) COVID-19 group, integrated by 66 patients who tested positive for COVID-19 (2) control group, composed of 32 healthy individuals who did not show any sign of disease for at least four weeks and were negative for COVID-19 in RT- PCR. In the proteomic study there were observed upregulations in CAZA1, ACTN4, and ANXA4, which are proteins related to the protective response against the virus disturbance, and the upregulation of TGM3, that is correlated to the oxidative damage in pulmonary tissue. We also showed the downregulation in cystatins and CA6 that can be involved in the sensory response to stimulus and possibly related to the presence of anosmia and dysgeusia during the COVID-19. Additionally, the presence of FGB in patients with severe COVID-19 but not in mild COVID-19 patients could indicate a higher viral aggregation and activation in these cases. In conclusion, the salivary proteome in patients with COVID-19 showed changes in proteins related to the protective response to viral infection, and the altered sensory taste perception that occur during the disease. Moreover, gGT and TEA could be potential biomarkers of respiratory complications that can occurs during COVID 19 although further larger studies should be made to corroborate this.

Proteomics ; Infectious diseases

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12

2022.

10879

14

objavljeno

2045-2322

10.1038/s41598-022-14830-6

Trošak objave rada u otvorenom pristupu

Povezanost rada

Veterinarska medicina

Poveznice
Indeksiranost